The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma

NCT01972672 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Beijing Shenogen Biomedical Co., Ltd

Collaborators